Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HF, Ausems MG, Menko FH, Gomez Garcia EB, Klijn JG, Hogervorst FB, van Houwelingen JC, van't Veer LJ, Rookus MA, van Leeuwen FE; Netherlands Collaborative Group on Hereditary Breast Cancer (HEBON).

J Med Genet. 2005 Sep;42(9):711-9.

2.

BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.

Sinilnikova OM, Mazoyer S, Bonnardel C, Lynch HT, Narod SA, Lenoir GM.

Fam Cancer. 2006;5(1):15-20. Review.

PMID:
16528604
3.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
4.

Management updates for women with a BRCA1 or BRCA2 mutation.

Nusbaum R, Isaacs C.

Mol Diagn Ther. 2007;11(3):133-44. Review.

PMID:
17570734
5.

Cancer risks among BRCA1 and BRCA2 mutation carriers.

Levy-Lahad E, Friedman E.

Br J Cancer. 2007 Jan 15;96(1):11-5. Review.

6.

Epidemiology of pancreatic cancer: an overview.

Ghadirian P, Lynch HT, Krewski D.

Cancer Detect Prev. 2003;27(2):87-93. Review.

PMID:
12670518
7.
8.

Etiology of cancer of the human ovary: a review.

Lingeman CH.

J Natl Cancer Inst. 1974 Dec;53(6):1603-18. Review.

PMID:
4612161
9.
10.

Cancer risk in laboratory workers: an emphasis on biological research.

Rachet B, Partanen T, Kauppinen T, Sasco AJ.

Am J Ind Med. 2000 Dec;38(6):651-65. Review.

PMID:
11071688
11.

[Familial incidence of ovarian cancer].

Hengrave G, De Grandi P.

J Gynecol Obstet Biol Reprod (Paris). 1986;15(7):863-71. Review. French.

PMID:
3543103
12.

The role of the BRCA2 gene in susceptibility to prostate cancer revisited.

Ostrander EA, Udler MS.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1843-8. doi: 10.1158/1055-9965.EPI-08-0556. Review.

13.

Time trends in hormone-dependent cancer.

Muir CS, Black RJ.

Prog Clin Biol Res. 1996;394:25-40. Review. No abstract available.

PMID:
8778799
14.

Hormonal carcinogenesis and environmental influences: background and overview.

Huff J, Boyd J, Barrett JC.

Prog Clin Biol Res. 1996;394:3-23. Review. No abstract available.

PMID:
8778803
15.

Is there a case for personalized therapy of pancreatic cancer?

Dragovich T.

Clin Adv Hematol Oncol. 2012 May;10(5):344-5. Review. No abstract available.

PMID:
22706549

Supplemental Content

Support Center